Report cover image

Global Plantar Fasciitis Treatment Market Growth, Size, Trends Analysis - By Treatment Type, By Indication, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jul 14, 2025
Length 242 Pages
SKU # SPER20337459

Description

Plantar Fasciitis Treatment Market Introduction and Overview

According to SPER market research, ‘Global Plantar Fasciitis Treatment Market Size- By Treatment Type, By Indication, By End-User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Plantar Fasciitis Treatment Market is predicted to reach 3.27 billion by 2034 with a CAGR of 9.57%.

Plantar fasciitis treatment encompasses a range of therapeutic approaches aimed at relieving symptoms and addressing the root causes of plantar fasciitis, which is a prevalent foot condition marked by inflammation and irritation of the plantar fascia. This thick band of tissue extends along the foot’s base, connecting the heel bone to the toes.

Restraints:Factors impeding the treatment market for plantar fasciitis involve the substantial expense associated with advanced therapies, including shock wave therapy and surgical options, which may be financially daunting for certain patients, particularly in economically disadvantaged areas. Furthermore, the insufficient awareness regarding plantar fasciitis and its corresponding treatments among various individuals is obstructing market expansion.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered
By Treatment Type, By Indication, By End-User

Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered
3M, A. Algeo Ltd, Bauerfeind USA Inc, Hanger, Inc, OrthoBethesda, OrthoMed, Inc, Ottobock, Pfizer, Inc, Revance Therapeutics, Inc, Sanofi.

Global Plantar Fasciitis Treatment Market Segmentation:


By Treatment Type: Based on the Treatment Type, Global Plantar Fasciitis Treatment Market is segmented as; Therapy, Medication Therapy, Surgery.

By Indication: Based on the Indication, Global Plantar Fasciitis Treatment Market is segmented as; Mild, Moderate, Severe.

By End-User: Based on the End-User, Global Plantar Fasciitis Treatment Market is segmented as; Hospitals, Orthopedic Clinics, Physiotherapy Centers, Other End-User.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

242 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Plantar Fasciitis Treatment Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Plantar Fasciitis Treatment Market
7. Global Plantar Fasciitis Treatment Market, By Treatment Type (USD Million) 2021-2034
7.1. Therapy
7.1.1. Orthotic devices
7.1.2. Shockwave therapy
7.1.3. Ultrasound therapy
7.1.4. Other therapies
7.2. Medication Therapy
7.2.1. Nonsteroidal anti-inflammatory drugs (NSAIDs)
7.2.2. Corticosteroid injections
7.2.3. Topical pain relievers
7.3. Surgery
7.3.1. Plantar fascia release
7.3.2. Gastrocnemius recession
7.3.3. Tendon transfer
8. Global Plantar Fasciitis Treatment Market, By Indication (USD Million) 2021-2034
8.1. Mild
8.2. Moderate
8.3. Severe
9. Global Plantar Fasciitis Treatment Market, By End-User (USD Million) 2021-2034
9.1. Hospitals
9.2. Orthopedic Clinics
9.3. Physiotherapy Centers
9.4. Other End-User
10. Global Plantar Fasciitis Treatment Market, (USD Million) 2021-2034
10.1. Global Plantar Fasciitis Treatment Market Size and Market Share
11. Global Plantar Fasciitis Treatment Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. 3 M
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Algeo Ltd
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Bauerfeind USA Inc
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Hanger, Inc
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. OrthoBethesda
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. OrthoMed, Inc
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Ottobock
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Pfizer, Inc
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Revance Therapeutics, Inc
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Sanofi
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us